CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme

• Yasuo Takashima,

  Roles Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

  http://orcid.org/0000-0001-8876-6673

  ⨯
• Atsushi Kawaguchi,

  Roles Data curation, Formal analysis, Investigation, Methodology

  Affiliation Center for Comprehensive Community Medicine, Faculty of Medicine, Saga University, Saga, Japan

  ⨯
• Azusa Hayano,

  Roles Investigation

  Affiliation Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• Ryuya Yamanaka

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: ryaman@koto.kpu-m.ac.jp

  Affiliation Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯